Surgical Biologics is the leader in
the development and manufacture
of placental-based allografts, having
produced and distributed more than
30,000 products for use in soft tissue
repair procedures since its inception.
There have been no adverse events
reported with Surgical Biologics
products.
epiFix® begins with donated human
placental tissue that is evaluated,
screened and recovered using
extensive acceptance and exclusion
criteria in compliance with US Food
and Drug Administration (FDA)
regulations, American Association
of Tissue Banks (AATB) Standards,
and state and local regulations as
appropriate. Surgical Biologics is
registered with the FDA and
accredited by the AATB.
Company’s Keywords:
placenta, amnion, amniotic membrane, allograft
<2
<2000000
<
<2006